Annovis Bio, Inc. (ANVS)
NYSE: ANVS · IEX Real-Time Price · USD
9.28
+4.01 (76.09%)
At close: Jul 2, 2024, 4:00 PM
9.60
+0.32 (3.45%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Annovis Bio Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Annovis Bio stock have an average target of 31.25, with a low estimate of 9.00 and a high estimate of 67. The average target predicts an increase of 236.75% from the current stock price of 9.28.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Annovis Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Reiterates $67 | Strong Buy | Reiterates | $67 | +621.98% | Jul 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +147.84% | Jun 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $23 | Strong Buy | Maintains | $30 → $23 | +147.84% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Apr 30, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $36 → $26 | Strong Buy | Maintains | $36 → $26 | +180.17% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.22
from -6.23
EPS Next Year
-1.86
from -1.22
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.10 | -1.38 | -1.70 |
| Avg | -1.22 | -1.86 | -1.85 |
| Low | -1.33 | -2.52 | -1.96 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.